Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs [version 1; peer review: 2 approved]
Background: Contraceptive-induced menstrual changes (CIMCs) can affect family planning (FP) users’ lives in both positive and negative ways, resulting in both opportunities and consequences. Despite this, and despite the important links between FP and menstrual health (MH), neither field adequately...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2022-04-01
|
Series: | Gates Open Research |
Subjects: | |
Online Access: | https://gatesopenresearch.org/articles/6-49/v1 |
_version_ | 1828213825708490752 |
---|---|
author | Kavita Nanda Emily Hoppes Julie Hennegan Chukwuemeka Nwachukwu Amanda Cordova-Gomez Diana L. Blithe Gustavo F. Doncel Hilary Critchley Lisa B. Haddad Laneta J. Dorflinger Jacqueline A. Maybin Amelia C.L. Mackenzie Carolina Sales Vieira Kelle Moley Alexandria Mickler Simon P.S. Kibira Chelsea B. Polis Funmilola M. OlaOlorun Katie M. Williams Marni Sommer Tanya Mahajan Eva Lathrop Kate H. Rademacher Katrina Wilson Marsden Solomon Lillian Rountree Lucy C. Wilson Bellington Vwalika |
author_facet | Kavita Nanda Emily Hoppes Julie Hennegan Chukwuemeka Nwachukwu Amanda Cordova-Gomez Diana L. Blithe Gustavo F. Doncel Hilary Critchley Lisa B. Haddad Laneta J. Dorflinger Jacqueline A. Maybin Amelia C.L. Mackenzie Carolina Sales Vieira Kelle Moley Alexandria Mickler Simon P.S. Kibira Chelsea B. Polis Funmilola M. OlaOlorun Katie M. Williams Marni Sommer Tanya Mahajan Eva Lathrop Kate H. Rademacher Katrina Wilson Marsden Solomon Lillian Rountree Lucy C. Wilson Bellington Vwalika |
author_sort | Kavita Nanda |
collection | DOAJ |
description | Background: Contraceptive-induced menstrual changes (CIMCs) can affect family planning (FP) users’ lives in both positive and negative ways, resulting in both opportunities and consequences. Despite this, and despite the important links between FP and menstrual health (MH), neither field adequately addresses CIMCs, including in research, product development, policies, and programs globally. Methods: In November 2020, a convening of both MH and FP experts reviewed the existing evidence on CIMCs and identified significant gaps in key areas. Results: These gaps led to the establishment of a CIMC Task Force in April 2021 and the development of the Global Research and Learning Agenda: Building Evidence on Contraceptive-Induced Menstrual Changes in Research, Product Development, Policies, and Programs Globally (the CIMC RLA), which includes four research agendas for (1) measurement, (2) contraceptive research and development (R&D) and biomedical research, (3) social-behavioral and user preferences research, and (4) programmatic research. Conclusions: Guided by the CIMC RLA, researchers, product developers, health care providers, program implementers, advocates, policymakers, and funders are urged to conduct research and implement strategies to address the beneficial and negative effects of CIMCs and support the integration of FP and MH. CIMCs need to be addressed to improve the health and well-being of women, girls, and other people who menstruate and use contraceptives globally. Disclaimer: The views expressed in this article are those of the authors. Publication in Gates Open Research does not imply endorsement by the Gates Foundation. |
first_indexed | 2024-04-12T14:55:49Z |
format | Article |
id | doaj.art-0480e91d1fcd4c31bd64de28f7cb861e |
institution | Directory Open Access Journal |
issn | 2572-4754 |
language | English |
last_indexed | 2024-04-12T14:55:49Z |
publishDate | 2022-04-01 |
publisher | F1000 Research Ltd |
record_format | Article |
series | Gates Open Research |
spelling | doaj.art-0480e91d1fcd4c31bd64de28f7cb861e2022-12-22T03:28:14ZengF1000 Research LtdGates Open Research2572-47542022-04-01614882Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs [version 1; peer review: 2 approved]Kavita Nanda0https://orcid.org/0000-0001-7650-2929Emily Hoppes1https://orcid.org/0000-0002-0178-4068Julie Hennegan2Chukwuemeka Nwachukwu3Amanda Cordova-Gomez4Diana L. Blithe5Gustavo F. Doncel6Hilary Critchley7https://orcid.org/0000-0003-1913-4044Lisa B. Haddad8Laneta J. Dorflinger9Jacqueline A. Maybin10Amelia C.L. Mackenzie11https://orcid.org/0000-0003-1721-805XCarolina Sales Vieira12Kelle Moley13Alexandria Mickler14Simon P.S. Kibira15https://orcid.org/0000-0002-7385-423XChelsea B. Polis16https://orcid.org/0000-0002-1031-7074Funmilola M. OlaOlorun17https://orcid.org/0000-0001-5544-2875Katie M. Williams18https://orcid.org/0000-0001-7643-5383Marni Sommer19Tanya Mahajan20Eva Lathrop21Kate H. Rademacher22https://orcid.org/0000-0001-7015-5073Katrina Wilson23Marsden Solomon24Lillian Rountree25Lucy C. Wilson26Bellington Vwalika27FHI 360, Durham, NC, 27701, USAFHI 360, Durham, NC, 27701, USAMaternal Child and Adolescent Health Program, Burnet Institute, Melbourne, VIC 3004, AustraliaUnited States Agency for International Development (USAID), Washington, District of Columbia, 20523, USAUnited States Agency for International Development (USAID), Washington, District of Columbia, 20523, USAContraceptive Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, 20892, USACONRAD, Eastern Virginia Medical School, Norfolk, Virginia, 23507, USAMRC Centre for Reproductive Health, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, EH8 9YL, UKCenter for Biomedical Research, Population Council, New York, New York, 10017, USAFHI 360, Durham, NC, 27701, USAMRC Centre for Reproductive Health, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, EH8 9YL, UKFHI 360, Durham, NC, 27701, USADepartment of Gynecology and Obstetrics, Ribeirao Preto Medical School, University of São Paulo, São Paulo, BrazilBill & Melinda Gates Foundation, Seattle, Washington, 98109, USAUnited States Agency for International Development (USAID), Washington, District of Columbia, 20523, USADepartment of Community Health and Behavioural Sciences, School of Public Health, Makerere University, Kampala, UgandaIndependent Researcher, Brooklyn, New York, USADepartment of Community Medicine, University of Ibadan, Ibadan, NigeriaFHI 360, Durham, NC, 27701, USADepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, New York, 10032, USAThe Pad Project, New Delhi, IndiaPopulation Services International, Washington, District of Columbia, 20526, USAFHI 360, Durham, NC, 27701, USAMSI Reproductive Choices, London, W1T 6LP, UKFHI 360, Durham, NC, 27701, USAFHI 360, Durham, NC, 27701, USARising Outcomes, Hillsborough, NC, 27278, USADepartments of Obstetrics and Gynaecology, University of Zambia School of Medicine, Lusaka, ZambiaBackground: Contraceptive-induced menstrual changes (CIMCs) can affect family planning (FP) users’ lives in both positive and negative ways, resulting in both opportunities and consequences. Despite this, and despite the important links between FP and menstrual health (MH), neither field adequately addresses CIMCs, including in research, product development, policies, and programs globally. Methods: In November 2020, a convening of both MH and FP experts reviewed the existing evidence on CIMCs and identified significant gaps in key areas. Results: These gaps led to the establishment of a CIMC Task Force in April 2021 and the development of the Global Research and Learning Agenda: Building Evidence on Contraceptive-Induced Menstrual Changes in Research, Product Development, Policies, and Programs Globally (the CIMC RLA), which includes four research agendas for (1) measurement, (2) contraceptive research and development (R&D) and biomedical research, (3) social-behavioral and user preferences research, and (4) programmatic research. Conclusions: Guided by the CIMC RLA, researchers, product developers, health care providers, program implementers, advocates, policymakers, and funders are urged to conduct research and implement strategies to address the beneficial and negative effects of CIMCs and support the integration of FP and MH. CIMCs need to be addressed to improve the health and well-being of women, girls, and other people who menstruate and use contraceptives globally. Disclaimer: The views expressed in this article are those of the authors. Publication in Gates Open Research does not imply endorsement by the Gates Foundation.https://gatesopenresearch.org/articles/6-49/v1family planning contraceptive menstrual health contraceptive-induced menstrual change CIMC menstrual changeeng |
spellingShingle | Kavita Nanda Emily Hoppes Julie Hennegan Chukwuemeka Nwachukwu Amanda Cordova-Gomez Diana L. Blithe Gustavo F. Doncel Hilary Critchley Lisa B. Haddad Laneta J. Dorflinger Jacqueline A. Maybin Amelia C.L. Mackenzie Carolina Sales Vieira Kelle Moley Alexandria Mickler Simon P.S. Kibira Chelsea B. Polis Funmilola M. OlaOlorun Katie M. Williams Marni Sommer Tanya Mahajan Eva Lathrop Kate H. Rademacher Katrina Wilson Marsden Solomon Lillian Rountree Lucy C. Wilson Bellington Vwalika Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs [version 1; peer review: 2 approved] Gates Open Research family planning contraceptive menstrual health contraceptive-induced menstrual change CIMC menstrual change eng |
title | Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs [version 1; peer review: 2 approved] |
title_full | Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs [version 1; peer review: 2 approved] |
title_fullStr | Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs [version 1; peer review: 2 approved] |
title_full_unstemmed | Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs [version 1; peer review: 2 approved] |
title_short | Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs [version 1; peer review: 2 approved] |
title_sort | global research and learning agenda for building evidence on contraceptive induced menstrual changes for research product development policies and programs version 1 peer review 2 approved |
topic | family planning contraceptive menstrual health contraceptive-induced menstrual change CIMC menstrual change eng |
url | https://gatesopenresearch.org/articles/6-49/v1 |
work_keys_str_mv | AT kavitananda globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT emilyhoppes globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT juliehennegan globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT chukwuemekanwachukwu globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT amandacordovagomez globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT dianalblithe globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT gustavofdoncel globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT hilarycritchley globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT lisabhaddad globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT lanetajdorflinger globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT jacquelineamaybin globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT ameliaclmackenzie globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT carolinasalesvieira globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT kellemoley globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT alexandriamickler globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT simonpskibira globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT chelseabpolis globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT funmilolamolaolorun globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT katiemwilliams globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT marnisommer globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT tanyamahajan globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT evalathrop globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT katehrademacher globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT katrinawilson globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT marsdensolomon globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT lillianrountree globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT lucycwilson globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved AT bellingtonvwalika globalresearchandlearningagendaforbuildingevidenceoncontraceptiveinducedmenstrualchangesforresearchproductdevelopmentpoliciesandprogramsversion1peerreview2approved |